The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects

The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have... Psychopharmacology (2017) 234:2499–2514 DOI 10.1007/s00213-017-4637-2 ORIGINAL INVESTIGATION The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal Band β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects 1 1,2 1 3 Amy W.M. Ewald & Peter J. Bosch & Aimee Culverhouse & Rachel Saylor Crowley & 3 3 1 Benjamin Neuenswander & Thomas E. Prisinzano & Bronwyn M. Kivell Received: 31 May 2016 /Accepted: 5 May 2017 /Published online: 23 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract activity, open arm times (EPM) or swimming behaviours Rationale Kappa-opioid receptor (KOPr) agonists have (FST) were seen with EOM (0.1 or 0.3 mg/kg, i.p.) or pre-clinical anti-cocaine and analgesic effects. However, side β-THP Sal B (1 or 2 mg/kg, i.p.). However, β-THP Sal B effects including sedation, dysphoria, aversion, anxiety and decreased time spent in the drug-paired chamber. depression limit their therapeutic development. The unique Conclusion EOM Sal B is more potent than Sal A and β-THP structure of salvinorin A has been used to develop longer Sal B in reducing drug-seeking behaviour with fewer side acting KOPr agonists. effects. EOM Sal B showed no effects on sucrose Objectives We evaluate two novel C-2 analogues of self-administration (0.1 mg/kg), locomotor, depressive-like, salvinorin http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects

Loading next page...
 
/lp/springer_journal/the-c-2-derivatives-of-salvinorin-a-ethoxymethyl-ether-sal-b-and-PolTjMq0wo
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Neurosciences; Pharmacology/Toxicology; Psychiatry
ISSN
0033-3158
eISSN
1432-2072
D.O.I.
10.1007/s00213-017-4637-2
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial